Abstract
Abstract
The study set out to determine the survival times of peripheral total parenteral nutrition (TPN) infusion sites in neonates using a prospective, single blind, randomised trial design. The effects of various concentrations of co-administered heparin was measured using survival analysis, and of other continuous variables using multivariate analysis, against a non-heparinized control group. The study was conducted in special care baby unit located within a specialist maternity hospital in London, United Kingdom. Heparin at 0.1, 0.25, 0.5 and 1 IU/ml was added to TPN infusions delivered through peripheral veins and the survival times of the infusions determined. For infusion sites receiving heparinized fluids, the relative risk of failure decreased and the median survival time increased as the heparin concentration increased, with a maximal effect at a heparin concentration of 0.5 IU/ml (P<0.001). Multivariate analysis using the Cox proportional hazard model confirmed the efficacy of heparin and high-lighted a history of infusion therapy and the co-administration of gentamicin (from a range of drugs analysed) as being risk factors associated with infusion site failure.
Conclusion
Intravenous infusion survival time can be prolonged using heparin additive at an optimal concentration of 0.5 IU/ml. This should also be of additional interest to paediatricians as heparin is an ubiquitous drug on neonatal units and its clinical use needs to be rationalised.
Similar content being viewed by others
Abbreviations
- TPN :
-
total parenteral nutrition
References
Alpan G, Eyal F, Springer C, Glick B, Goder K, Armon J (1981) Heparinization of alimentation solutions administered through peripheral veins in premature infants: a controlled study. Paediatrics 74: 375–378
Cox DR (1972) Regression models and lifetables. J Roy Stat Soc B 34: 187–220
Durand M, Barnett M (1992) Heparin in parenteral feeding. Effect of heparin and low molecular weight heparin on lipid emulsions and all-in-one admixtures. Br J Intensive Care Jan/Feb: 10–20
Hecker JF (1992) Potential for extending survival of peripheral intravenous infusions. BMJ 304: 619–624
Hecker JF, Duffy B, Fong T, Wyer M (1991) Failure of intravenous infusions in neonates. J Paediatr Child Health 78: 175–179
Moclair AE, Hecker JF, Willson A, Bates IP (1992) Prolonging the survival of peripheral infusion sites in neonates with low dose heparin. Int J Pharm Pract 1: 198–201
Nelson DB, Garland JS (1987) The natural history of Teflon catheter-associated phlebitis in children. Am J Dis Child 141: 1090–1094
Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al (1977) Design and analysis of randomised clinical trials requiring prolonged observation of each patient. (ii) Analysis and examples. Br J Cancer 35: 1–39
Phelps SJ, Helms RA (1987) Risk factors affecting infiltration of peripheral venous lines in infants. J Pediatr 111: 384–389
Thomas PH (1989) In-line terminal filtration of intravenous fluids and its effect on cannula patency in neonates. Proc. Guild Hosp Pharm 26: 3–10
Treas LS, Latinis-Bridges B (1992) Efficacy of heparin in peripheral venous infusion in neonates. J Obstet Gynaecol Neonat Nurs 21: 214–219
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moclair, A., Bates, I. The efficacy of heparin in maintaining peripheral infusions in neonates. Eur J Pediatr 154, 567–570 (1995). https://doi.org/10.1007/BF02074836
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02074836